Eversept Partners, LP - FATE THERAPEUTICS INC ownership

FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of FATE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$439,541
-86.1%
43,562
-69.2%
0.04%
-86.2%
Q3 2022$3,172,315
-82.4%
141,558
-80.5%
0.28%
-78.5%
Q2 2022$18,004,801
+1.8%
726,586
+59.3%
1.28%
-5.7%
Q1 2022$17,681,407
+18.6%
456,059
+79.0%
1.36%
+42.6%
Q4 2021$14,907,763
-3.6%
254,790
-2.3%
0.95%
-11.3%
Q3 2021$15,463,247
-48.6%
260,895
-24.7%
1.07%
-46.4%
Q2 2021$30,059,456
+13.3%
346,347
+7.6%
2.00%
+0.5%
Q1 2021$26,529,112
-27.0%
321,760
-19.5%
1.99%
-53.2%
Q4 2020$36,326,444
+69.9%
399,499
-25.3%
4.26%
-10.3%
Q3 2020$21,385,389
+17.3%
535,036
+0.7%
4.75%
+90.2%
Q2 2020$18,227,462
+168.7%
531,258
+73.9%
2.50%
+48.1%
Q1 2020$6,784,822
-3.9%
305,485
-15.3%
1.69%
+35.4%
Q4 2019$7,058,038
+223.1%
360,656
+156.4%
1.25%
+83.8%
Q3 2019$2,184,388
-50.6%
140,656
-35.4%
0.68%
-45.2%
Q2 2019$4,422,477
-28.1%
217,856
-37.8%
1.24%
-31.0%
Q1 2019$6,149,693
+190.5%
350,011
+112.1%
1.79%
+56.5%
Q4 2018$2,116,950165,0001.15%
Other shareholders
FATE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
JOHNSON & JOHNSON 3,379,064$34,0959.92%
Redmile Group, LLC 12,957,222$130,738,3705.35%
GCM Grosvenor Holdings, LLC 1,037,256$10,465,9132.67%
Casdin Capital, LLC 2,050,000$20,684,5001.60%
DAFNA Capital Management LLC 550,940$5,558,9851.57%
Artal Group S.A. 2,600,000$26,2341.46%
Monaco Asset Management SAM 250,000$2,522,5000.76%
Parametrica Management Ltd 32,254$325,4430.67%
Boxer Capital, LLC 1,250,000$12,612,5000.66%
Bellevue Group AG 4,861,279$49,050,3050.65%
View complete list of FATE THERAPEUTICS INC shareholders